Blueshift Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-1,561
Closed -$244K – 505
2025
Q3
$244K Buy
+1,561
New +$248K 0.08% 358
2024
Q4
– Sell
-2,264
Closed -$446K – 388
2024
Q3
$446K Buy
+2,264
New +$471K 0.11% 214
2022
Q4
– Sell
-2,155
Closed -$424K – 401
2022
Q3
$424K Buy
2,155
+278
+15% +$60K 0.09% 316
2022
Q2
$402K Buy
+1,877
New +$459K 0.07% 372
2022
Q1
– Sell
-1,446
Closed -$545K – 876
2021
Q4
$545K Sell
1,446
-12,296
-89% -$4.78M 0.05% 449
2021
Q3
$5.67M Buy
13,742
+10,886
+381% +$4.52M 0.32% 69
2021
Q2
$1.06M Buy
+2,856
New +$954K 0.06% 341
2021
Q1
– Sell
-3,846
Closed -$961K – 884
2020
Q4
$961K Buy
+3,846
New +$916K 0.11% 275
2020
Q3
– Sell
-5,686
Closed -$991K – 624
2020
Q2
$991K Buy
+5,686
New +$907K 0.16% 183
2019
Q3
– Sell
-10,088
Closed -$1.43M – 758
2019
Q2
$1.43M Buy
+10,088
New +$1.37M 0.19% 170
2019
Q1
– Sell
-14,772
Closed -$1.67M – 741
2018
Q4
$1.67M Buy
+14,772
New +$1.85M 0.31% 65

Other funds holding CRL

Blueshift Asset Management's CRL Position: Q4 2025 in Review

Blueshift Asset Management sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 1,561 shares — an estimated $244K sold.

Blueshift Asset Management first reported a position in CRL in Q4 2018 and held it in 11 quarters. The position peaked at $5.67M in Q3 2021. 583 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Blueshift Asset Management reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Blueshift Asset Management sold 1,561 Charles River Laboratories shares in Q4 2025, an estimated $244K.
  • Blueshift Asset Management first reported a position in Charles River Laboratories in Q4 2018 and held it in 11 quarters.
  • Blueshift Asset Management's Charles River Laboratories position peaked at $5.67M in Q3 2021.
  • 583 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Blueshift Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.